Publications by authors named "Stephan Weidinger"

Claim this Profile
I
Improvement and maintenance of clinical outcome assessments in atopic dermatitis with amlitelimab.
Andrew Blauvelt, Raj Chovatiya, Joseph F Merola, Stephan Weidinger, Ken Igawa

J Eur Acad Dermatol Venereol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of a Gel Containing the Defined Microalgae Extract Spiralin® on the Skin Microbiome and Clinical Activity in Atopic Dermatitis: A Double-Blind, Intraindividual Vehicle-Controlled Proof-Of-Concept Study.
Kristian Reich, Natalie Trettel, Jeremias L K Reich, Christina Sorbe, Thomas Bickert, Stephan Weidinger

Skin Pharmacol Physiol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetic and Pharmacodynamic Modeling for the Prediction of the Extended Amlitelimab Phase 3 Dosing Regimen in Atopic Dermatitis.
Gilles Tiraboschi, Kim Papp, Thomas Bieber, Stephan Weidinger, Lisa Beck

CPT Pharmacometrics Syst Pharmacol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large Eczema Area and Severity Index response at 2-year follow-up of patients treated with dupilumab in routine care of atopic dermatitis: results from the national registry TREATgermany.
Luise Heinrich, Thomas Birkner, Susanne Abraham, Sascha Gerdes, Tatjana Honstein, Stephan Weidinger

Skin Health Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The inflammatory skin disease map: an interactive computational resource focused on psoriasis and atopic dermatitis molecular mechanisms.
Marcio L Acencio, Oxana Lopata, Ahmed A Hemedan, Nick Dand, Stephan Weidinger

Br J Dermatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Post Hoc Analysis of Atopic Dermatitis of the Head and Neck and Other Body Regions from the Amlitelimab STREAM-AD Phase 2b Study.
Adam Reich, Andrew Blauvelt, Stephan Weidinger, Vivian Y Shi, Norito Katoh

Dermatol Ther (Heidelb)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tailoring Abrocitinib Treatment for Moderate-to-Severe Atopic Dermatitis to Patient Disease Course: A Narrative Review.
Jonathan I Silverberg, Eric Simpson, Melinda Gooderham, Stephan Weidinger, Melissa Watkins

Dermatol Ther (Heidelb)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Collagen XXIII (COL23A1): A novel risk factor for eczema herpeticum.
Shruti Chopra, Jana Zeitvogel, Stephan Traidl, Ilona Klug, Elke Rodriguez, Stephan Weidinger

J Allergy Clin Immunol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining "Flares" in Atopic Dermatitis: A Narrative Review.
Joseph F Merola, Stephan Weidinger, Sally Y Tan, Kassim Rahawi, Cori Gray

Am J Clin Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of upadacitinib in atopic dermatitis in randomized clinical trials across 6 years.
Christopher G Bunick, Alan D Irvine, Jonathan I Silverberg, Emma Guttman-Yassky, Mona Shahriari, Stephan Weidinger

J Eur Acad Dermatol Venereol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of lebrikizumab in adult and adolescent patients with moderate-to-severe atopic dermatitis inadequately controlled with or ineligible for ciclosporin A: a placebo-controlled, randomized phase IIIb clinical study (ADvantage).
Richard B Warren, Marjolein de Bruin-Weller, Athanasios Tsianakas, Abdallah Khemis, Jacek C Szepietowski, Stephan Weidinger

Br J Dermatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dissecting key contributions of T2 and T17 cytokines to atopic dermatitis pathophysiology.
Luca D Meesters, Janou A Y Roubroeks, Aranka Gerritsen, Niels Velthuijs, Jaimy A Klijnhout, Stephan Weidinger

J Allergy Clin Immunol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing Federated Analysis Using DataSHIELD in the DREAM TO TREAT Atopic Dermatitis Registries Collaboration.
Niels Steen Krogh, David Prieto-Merino, Bolaji Coker, Thomas Birkner, Ahmet Akkoc, Stephan Weidinger

J Invest Dermatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biologics to Treat Atopic Dermatitis: Effectiveness, Safety, and Future Directions.
Marjolein S de Bruin-Weller, Celeste M Boesjes, Roselie A Achten, Lisa A Beck, Alan D Irvine, Stephan Weidinger

Allergy· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-Year Efficacy and Safety of Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Long-Term Extension (ADjoin).
Emma Guttman-Yassky, Stephan Weidinger, Eric L Simpson, Melinda Gooderham, Alan D Irvine

Dermatol Ther (Heidelb)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vitro Evidence Demonstrating the Nondepleting Mechanism of Action of Amlitelimab, an OX40 Ligand Monoclonal Antibody.
James G Krueger, Brian S Kim, Stephan Weidinger, Yoko Kataoka, John T O'Malley

Acta Derm Venereol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelin-2 from Keratinocytes and Its Association with Itch in Skin Diseases.
Yumeng Dong, Mrinal K Sarkar, Yuntian Wu, Xianying Xing, Matthew T Patrick, Stephan Weidinger

J Invest Dermatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amlitelimab, an anti-OX40 ligand antibody, for atopic dermatitis: a plain language summary of STREAM-AD clinical study.
Stephan Weidinger, Andrew Blauvelt, Kim A Papp, Adam Reich, Chih-Hung Lee

Immunotherapy· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Childhood Asthma and Allergy Are Related to Accelerated Epigenetic Aging.
Miriam Leskien, Elisabeth Thiering, Zhebin Yu, Anke Huels, Yueli Yao, Stephan Weidinger

Allergy· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocol.
Elizaveta Gribaleva, Niels Steen Krogh, David Prieto-Merino, Bolaji Coker, Abaigeal Jackson, Stephan Weidinger

Skin Health Dis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory Skin Diseases: The Importance of Immunological Signatures.
Natalie Garzorz-Stark, Stephan Weidinger, Michael Sticherling, Kamran Ghoreschi, Alexander Enk

Dtsch Arztebl Int· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Moderate-to-severe Atopic Dermatitis with Upadacitinib: Results from an Interim Analysis of the TREATgermany Registry.
Barbara Kind, Luise Heinrich, Thomas Werfel, Jochen Schmitt, Stephan Weidinger

Acta Derm Venereol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Achievement of High Treatment Targets in Moderate-to-Severe Atopic Dermatitis with Upadacitinib: Real-World Evidence from the Observational UP-TAINED Study.
Stephan Weidinger, Tobias Schadeck, Felix Jacobs, Ansgar Weyergraf, Dariusch Mortazawi

Dermatol Ther (Heidelb)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The importance of registries in clinical practice: Insights from the national atopic dermatitis registry TREATgermany.
Tatjana Honstein, Barbara Kind, Dora Stölzl, Inken Harder, Sigrid Müller, Stephan Weidinger

Allergol Select· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targets.
Nick Dand, Philip E Stuart, John Bowes, David Ellinghaus, Joanne Nititham, Stephan Weidinger

Nat Commun· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis